USC and CHLA awarded $8 million to expand access to cell and gene therapy clinical trials

USC and CHLA awarded million to expand access to cell and gene therapy clinical trials

USC and CHLA awarded $8 million to expand access to cell and gene therapy clinical trials

by admin | Dec 6, 2022 | News & Opinions

CIRM-funded USC+CHLA Alpha Clinic boosts capacity for clinical and translational research, community outreach, training and manufacturing By Wayne Lewis – Keck School of Medicine of USC The California Institute for Regenerative Medicine (CIRM), the state’s stem...

Secret shopper studies: an unorthodox design that measures inequities in healthcare access

by admin | Dec 5, 2022 | News & Opinions

by Kelsey A. Rankin, Alison Mosier-Mills, Walter Hsiang & Daniel H. Wiznia – BMC Archives of Public Health Abstract Secret shopper studies are particularly potent study designs that allow for the gathering of objective data for a variety of research...

Fitness program for blood stem cells: TAZ protein protects from age-related loss of function

by admin | Dec 1, 2022 | News & Opinions

by by Kerstin Wagner, Leibniz-Institut für Alternsforschung – Fritz-Lipmann-Institut e.V. (FLI) – Phys.org Image: Hematopoietic stem cells age very heterogeneously. The TAZ protein, a co-activator of the Hippo signaling pathway, can protect blood stem...

Human synovial mesenchymal stem cells show time-dependent morphological changes and increased adhesion to degenerated porcine cartilage

by admin | Dec 1, 2022 | News & Opinions

by Takahiro Tanimoto, Kentaro Endo, Yuriko Sakamaki, Nobutake Ozeki, Hisako Katano, Mitsuru Mizuno, Hideyuki Koga & Ichiro Sekiya – Scientific Reports Abstract The possibility that mesenchymal stem cells (MSCs) can adhere to partial defects or degenerative...

Greenstone Bio Secures .3M from CIRM for iPSC-derived Cardiovascular Cell Technologies

Greenstone Bio Secures $1.3M from CIRM for iPSC-derived Cardiovascular Cell Technologies

by admin | Nov 30, 2022 | News & Opinions

By By Cade Hildreth, BioInformant Palo Alto, CA – Greenstone Biosciences, Inc. (“Greenstone Bio”), a commercial-stage computational biology company, announces that the Company has received a DISC0 grant funding from the California Institute of Regenerative Medicine...

Second death linked to potential antibody treatment for Alzheimer’s disease

by admin | Nov 28, 2022 | News & Opinions

By Charles Piller – Science image caption: There are two hallmarks of Alzheimer’s dementia, amyloid-beta protein deposits known as plaques among brain cells (yellow-orange bundles), and tangles of a protein called tau inside neurons (wiry objects inside the...